Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models

• Príomhchruthaitheoirí: Bissonnette Reid P (Údar), Hill Jamal (Údar), Zhang Yun (Údar), Kittrell Frances S (Údar), Gaddis Sally (Údar), Levy Carla C (Údar), Hu Yuhui (Údar), Abba Martin C (Údar), Medina Daniel (Údar), Brown Powel H (Údar), Aldaz C (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: BMC, 2008-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>The rexinoid bexarotene (LGD1069, Targretin) is a highly selective retinoid × receptor (RXR) agonist that inhibits the growth of pre-malignant and malignant breast cells. Bexarotene was shown to suppress the development of breast can...